Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Articles Tagged "funding"

Articulus Bio Gains Funding, Focusing on Total Ankle Replacement

by BONEZONE | Jan 2018

The company is addressing the issue of wear debris and seeks capital to collect data on sub-assembly components of its Tendonoid™ Web Joint technology.... Read more »

Surgical Assistance: Milestones and Funding

by BONEZONE | Oct 2017

Within the second half of 2017, we’ve noticed a jump in announcements pertaining to what we call “surgical assistance” tools: platforms designed to improve ease of use, support a personalized implant fit for patients, etc. Here’s what’s been making the headlines.... Read more »

Arthroscopy/Soft Tissue Technologies to Watch: 1H17 Funding Recap

by BONEZONE | Jul 2017

Funding announcements that we tracked from orthopaedic companies in 1H17 included eight arthroscopy/soft tissue-related technologies we’d like to highlight because of their novelty and early-stage backing.... Read more »

Medin Recapitalizes, Raises New Capital with Financial Partner

by BONEZONE | Mar 2017

Medin Technologies continues to manufacture sterilization cases and trays for the orthopaedic industry.  ... Read more »

Teleflex Awarded U.S. Army Grant to Develop Anti-Biofilm Orthopaedic Device

by BONEZONE | Oct 2014

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Orchid Orthopedic Solutions Receives Training Grant

by BONEZONE | Sep 2014

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Surgical Frontiers Closes $7 Million Fund

by BONEZONE | Aug 2014

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Round2Funding Investment Portal Launches to Connect Investors with Early Stage Healthcare Companies

by BONEZONE | Mar 2014

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Polymer Composite May Eliminate Bone Formation in Soft Tissue

by BONEZONE | Oct 2012

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Squadron Capital Agrees to Provide Financing for OEM Customer

by BONEZONE | May 2012

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Funding Activity in Orthopaedics and Spine

by BONEZONE | Dec 2011

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »